Healthcare resource utilization and direct medical costs associated with index and recurrent Clostridioides difficile infection: a real-world data analysis-Reference-Cited by-同舟云学术

Healthcare resource utilization and direct medical costs associated with index and recurrent Clostridioides difficile infection: a real-world data analysis

Published:2020-02-13 Issue:6 Volume:23 Page:603-609
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Feuerstadt Paul¹²,Stong Laura³,Dahdal David N.³,Sacks Naomi⁴⁵,Lang Kathleen⁴,Nelson Winnie W.³

Affiliation:

1. Gastroenterology Center of Connecticut, Hamden, CT, USA;

2. Division of Gastroenterology, Yale University School of Medicine, New Haven, CT, USA;

3. Ferring Pharmaceuticals Inc, Parsippany, NJ, USA;

4. Precision Health Economics and Outcomes Research, Boston, MA, USA;

5. Department of Public Health, Tufts University School of Medicine, Boston, MA, USA

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2020.1724117

Reference31 articles.

1. Clostridium difficile infection: a review of current and emerging therapies

2. Clostridium difficile infection

3. Centers for Disease Control and Prevention. Clostridioides difficile infection [Internet]; [cited 2019 Aug 13]. Available from: https://www.cdc.gov/hai/organisms/cdiff/cdiff_infect.html

4. The rise in Clostridium difficile infection incidence among hospitalized adults in the United States: 2001-2010

5. Clostridium difficile Infection

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Host-defense piscidin peptides as antibiotic adjuvants against Clostridioides difficile;PLOS ONE;2024-01-22

2. Efficacy and Health-Related Quality of Life Impact of Fecal Microbiota, Live-jslm: A Post Hoc Analysis of PUNCH CD3 Patients at First Recurrence of Clostridioides difficile Infection;Infectious Diseases and Therapy;2024-01

3. Characterizing the Clinical Adoption of Medical AI Devices through U.S. Insurance Claims;NEJM AI;2023-12-11

4. Changes in Commercial Insurance Claims for Contraceptive Services During the Beginning of the COVID-19 Pandemic—United States, January 2019–September 2020;Women's Health Issues;2023-12

5. Review Article: Safety of Live Biotherapeutic Products Used for the Prevention of Clostridioides difficile Infection Recurrence;Clinical Infectious Diseases;2023-12-01